In 2023, the sales of Musculo-Skeletal System Medicine in Chile stood at 330.7 million USD PPP. The forecasted data from 2024 to 2028 shows a steady year-on-year growth. Specifically, the sales are expected to increase from 339.3 million USD PPP in 2024 to 371.9 million USD PPP in 2028. This represents an average annual growth rate (CAGR) of approximately 2.3% over the five-year period.

Future trends to watch for include:

Advancements in medical technology and treatments for musculoskeletal conditions.
Increasing aging population which could drive higher demand for musculoskeletal medicines.
Potential policy changes regarding healthcare funding and drug pricing.
Emergence of new market entrants and competitive dynamics within the pharma sector in Chile.
Shifts in consumer behavior and health consciousness that may impact sales.